Neogen Total Assets 2012-2025 | NEOG
Neogen total assets from 2012 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
|
Neogen Annual Total Assets (Millions of US $) |
|
|---|---|
| 2025 | $3,444 |
| 2024 | $4,549 |
| 2023 | $4,554 |
| 2022 | $993 |
| 2021 | $920 |
| 2020 | $797 |
| 2019 | $696 |
| 2018 | $618 |
| 2017 | $528 |
| 2016 | $450 |
| 2015 | $392 |
| 2014 | $345 |
| 2013 | $291 |
| 2012 | $252 |
| 2011 | $220 |
|
Neogen Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-11-30 | $3,360 |
| 2025-08-31 | $3,378 |
| 2025-05-31 | $3,444 |
| 2025-02-28 | $4,036 |
| 2024-11-30 | $4,054 |
| 2024-08-31 | $4,503 |
| 2024-05-31 | $4,549 |
| 2024-02-29 | $4,582 |
| 2023-11-30 | $4,602 |
| 2023-08-31 | $4,561 |
| 2023-05-31 | $4,554 |
| 2023-02-28 | $4,509 |
| 2022-11-30 | $4,563 |
| 2022-08-31 | $977 |
| 2022-05-31 | $993 |
| 2022-02-28 | $981 |
| 2021-11-30 | $968 |
| 2021-08-31 | $932 |
| 2021-05-31 | $920 |
| 2021-02-28 | $880 |
| 2020-11-30 | $846 |
| 2020-08-31 | $822 |
| 2020-05-31 | $797 |
| 2020-02-29 | $774 |
| 2019-11-30 | $751 |
| 2019-08-31 | $721 |
| 2019-05-31 | $696 |
| 2019-02-28 | $673 |
| 2018-11-30 | $660 |
| 2018-08-31 | $641 |
| 2018-05-31 | $618 |
| 2018-02-28 | $596 |
| 2017-11-30 | $581 |
| 2017-08-31 | $547 |
| 2017-05-31 | $528 |
| 2017-02-28 | $507 |
| 2016-11-30 | $487 |
| 2016-08-31 | $469 |
| 2016-05-31 | $450 |
| 2016-02-29 | $432 |
| 2015-11-30 | $426 |
| 2015-08-31 | $409 |
| 2015-05-31 | $392 |
| 2015-02-28 | $378 |
| 2014-11-30 | $366 |
| 2014-08-31 | $358 |
| 2014-05-31 | $345 |
| 2014-02-28 | $330 |
| 2013-11-30 | $320 |
| 2013-08-31 | $308 |
| 2013-05-31 | $291 |
| 2013-02-28 | $281 |
| 2012-11-30 | $270 |
| 2012-08-31 | $261 |
| 2012-05-31 | $252 |
| 2012-02-29 | $240 |
| 2011-11-30 | $234 |
| 2011-08-31 | $228 |
| 2011-05-31 | $220 |
| 2011-02-28 | $209 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.034B | $0.895B |
| Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $210.647B | 24.28 |
| EssilorLuxottica (ESLOY) | France | $144.389B | 0.00 |
| Stryker (SYK) | United States | $137.523B | 27.31 |
| Boston Scientific (BSX) | United States | $135.199B | 30.92 |
| Medtronic (MDT) | Ireland | $126.407B | 17.51 |
| Medline (MDLN) | United States | $58.001B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.030B | 0.00 |
| Agilent Technologies (A) | United States | $38.508B | 24.34 |
| ResMed (RMD) | United States | $36.951B | 25.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.909B | 17.17 |
| Koninklijke Philips (PHG) | Netherlands | $27.434B | 17.92 |
| Insulet (PODD) | United States | $19.996B | 62.06 |
| Terumo (TRUMY) | Japan | $19.854B | 22.35 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.202B | 10.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.668B | 0.00 |
| Baxter (BAX) | United States | $9.962B | 8.04 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.437B | 30.34 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.369B | 13.31 |
| Envista Holdings (NVST) | United States | $4.002B | 22.96 |
| BillionToOne (BLLN) | United States | $3.934B | 0.00 |
| ICU Medical (ICUI) | United States | $3.783B | 24.02 |
| Haemonetics (HAE) | United States | $3.281B | 14.60 |
| Prestige Consumer Healthcare (PBH) | United States | $3.114B | 14.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.223B | 14.29 |
| Perrigo (PRGO) | Ireland | $2.077B | 5.20 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 39.18 |
| AtriCure (ATRC) | United States | $1.910B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.683B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Green Thumb Industries (GTBIF) | United States | $1.620B | 71.00 |
| AdaptHealth (AHCO) | United States | $1.408B | 20.39 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.398B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.342B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.192B | 353.71 |
| Capricor Therapeutics (CAPR) | United States | $1.106B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.019B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.874B | 9.87 |
| Omeros (OMER) | United States | $0.869B | 0.00 |
| Valneva SE (VALN) | France | $0.841B | 0.00 |
| CeriBell (CBLL) | United States | $0.796B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.568B | 15.40 |
| Cerus (CERS) | United States | $0.476B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.433B | 73.77 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Evolus (EOLS) | United States | $0.328B | 0.00 |
| Quanterix (QTRX) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 22.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.237B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.235B | 138.00 |
| TerrAscend (TSNDF) | Canada | $0.228B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.32 |
| Sanara MedTech (SMTI) | United States | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.186B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.178B | 0.00 |
| Accendra Health (ACH) | United States | $0.170B | 1.71 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Apyx Medical (APYX) | United States | $0.147B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.140B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.87 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| Biote (BTMD) | United States | $0.103B | 4.52 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.08 |
| Nephros (NEPH) | United States | $0.053B | 38.00 |
| Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 14.93 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |